112 filings
Page 2 of 6
8-K
7fe6 h3gjz
3 Aug 22
NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
9:34am
8-K
bc3m3i1
2 Jun 22
NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders
4:05pm
8-K
op7g2r7qyg6pe
16 May 22
NeuroOne Provides Evo® sEEG Update
4:38pm
8-K
8rsvalyayqil6
12 May 22
NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:17pm
8-K
iewpuh q0xa0gddotvts
25 Mar 22
Other Events
4:45pm
8-K
96e hd4w81
14 Feb 22
NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
6xkuusoqquth
4 Feb 22
Departure of Directors or Certain Officers
4:10pm
8-K
y78numzxs9c0iien4gev
15 Dec 21
NeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021
8:15am
8-K
37i5s8gpbv
14 Oct 21
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
9:00am
8-K
uun5btmipf2aht7p
4 Oct 21
Other Events
4:48pm
8-K
fdcb72o5 ok0m
7 Sep 21
NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode
4:28pm
8-K
yulilzykas6yrfruzs
13 Aug 21
NeuroOne Reports Third Quarter Fiscal 2021 Financial Results and Corporate Update
8:05am
8-K
aznfjwyq4ql3ti
24 Jun 21
Changes in Registrant's Certifying Accountant
4:15pm
8-K
o8ngmkur
8 Jun 21
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
aiufpc395ac1kw782xs
25 May 21
NeuroOne Announces Approval for Nasdaq Capital Market Listing;Trading Expected to Commence Tomorrow May 26th, 2021 Under the Symbol NMTC
5:20pm
8-K
9ay1gt
31 Mar 21
NeuroOne Medical Technologies Corporation Announces Reverse Stock Split as Part of Uplisting Strategy to Major Exchange
9:13am
8-K
a5gavqjd
23 Feb 21
NeuroOne Medical Technologies Corporation Announces Successful Completion of First
8:12am
8-K
tj494
15 Jan 21
NeuroOne Medical Technologies Corporation Announces Private Placement
8:08am
8-K
2d8rujs8qd nmqvd4
7 Jan 21
NeuroOne Medical Technologies Corporation Appoints Ronald McClurg, Experienced Financial Industry Executive, as Chief Financial Officer
8:59am
8-K
k5h4 9z3y2fn
6 Oct 20
NeuroOne Medical Technologies Corporation Provides Commercialization Update for EVO Cortical Electrode
8:29am